美国

我们是谁

  • 4 月 5, 2022
    A Study of a Personalized Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer
  • 4 月 5, 2022
    在晚期实体瘤受试者中评估 MEDI5752 的研究
  • 4 月 5, 2022
    A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)
  • 4 月 5, 2022
    Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
  • 4 月 5, 2022
    对转移性癌症患者施用经基因工程改造可表达对新抗原有反应的 T 细胞受体的自体 T 细胞
  • 4 月 5, 2022
    BMS-986253与Nivolumab或Nivolumab加Ipilimumab联合治疗晚期癌症的研究
  • 4 月 5, 2022
    Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer
  • 4 月 5, 2022
    INNATE: Immunotherapy During Neoadjuvant Therapy for Rectal Cancer
  • 4 月 5, 2022
    Safety, Tolerability and Pharmacokinetics of AZD1775 (Adavosertib) Plus MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumours
  • 4 月 5, 2022
    评估THOR-707对晚期或转移性实体瘤成人受试者安全性和治疗活性的研究